Stem-Cell Research
Nicotinamide induces stem cell differentiation into insulin cells
Published in Obesity and Diabetes Week, November 10th, 2003
According to a study from Spain, "In contrast to the consistent observation that methods that promote proliferation also dedifferentiate insulin-producing cells, useful in vitro differentiation protocols must drive both proliferation and differentiation."
"We herein describe an strategy in which the combination of nutrient restriction and nicotinamide supplementation results in a consistent increase in the mass of insulin-producing cells," wrote P. Vaca and colleagues at the University Miguel Hernandez.
Vaca and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Survival and Mortality
Mammary grafting increases mediastinitis risk after coronary bypass - Protein Folding
A new molecular culprit found for type 2 diabetes, Alzheimer and Parkinson - Diabetes Pathogenesis
Inflammatory mediators and beta-cell failure link type 1 and 2 diabetes - Genetics and Genomics
MODY is model of genotype/phenotype interactions in type 2 diabetes - Hypertension Therapy
Doxazosin can lower atherosclerosis risk in hypertensive patients with insulin resistance - Appetite Control
Clinical study of appetite control tablets shows significant results - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
